A. J. Van der Lely

发表

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly.

N. Erler, A. J. van der Lely, L. Hofland, 2020, European journal of endocrinology.

Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system.

A. Langerak, S. Lamberts, A. J. van der Lely, 2003, The Journal of clinical endocrinology and metabolism.

Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor–Interacting Protein–mutated Pediatric Somatotropinoma

M. Buchfelder, R. Coras, A. J. van der Lely, 2021, AACE clinical case reports.

Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case–Control Study

M. Buchfelder, M. Krebs, C. Boguszewski, 2021, The Journal of clinical endocrinology and metabolism.

Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression

A. J. van der Lely, L. Hofland, S. Neggers, 2018, The Journal of clinical endocrinology and metabolism.

Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)

A. J. van der Lely, P. Delhanty, I. Haitsma, 2017, The Journal of clinical endocrinology and metabolism.

Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly

X. Badia, M. Buchfelder, E. Ghigo, 2017, Pituitary.

The introduction of the IDS-iSYS total IGF-1 assay may have far-reaching consequences for diagnosis and treatment of GH deficiency.

S. Lamberts, A. J. van der Lely, L. Hofland, 2015, The Journal of clinical endocrinology and metabolism.

Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial.

B. Glaser, M. Korbonits, S. Melmed, 2015, The Journal of clinical endocrinology and metabolism.

Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells.

S. Achilefu, S. Achilefu, A. Houtsmuller, 2003, American journal of physiology. Endocrinology and metabolism.

Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader–Willi syndrome

M. Tauber, A. J. van der Lely, P. Delhanty, 2015, Endocrine.

Ghrelin secretion is inhibited by glucose load and insulin‐induced hypoglycaemia but unaffected by glucagon and arginine in humans

E. Arvat, E. Ghigo, F. Riganti, 2004, Clinical endocrinology.

In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas

J. Kros, S. Lamberts, A. J. van der Lely, 2017, The Journal of clinical endocrinology and metabolism.

Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance.

M. Bidlingmaier, S. Lamberts, C. Strasburger, 2001, The Journal of clinical endocrinology and metabolism.

The potential role of biomarkers in predicting gestational diabetes

A. J. van der Lely, J. van der Linden, A. J. Van der Lely, 2016, Endocrine connections.

Extra-hepatic Acromegaly.

A. J. van der Lely, S. Neggers, A. J. Van der Lely, 2013, European endocrinology.

Hypothesis: Extra-hepatic acromegaly: a new paradigm?

J. Kopchick, J. Jørgensen, A. J. van der Lely, 2011, European journal of endocrinology.

IGFBP-2 and aging: a 20-year longitudinal study on IGFBP-2, IGF-I, BMI, insulin sensitivity and mortality in an aging population.

L. Ferrucci, D. Rizopoulos, J. Egan, 2019, European journal of endocrinology.

Acetylcholine regulates ghrelin secretion in humans.

E. Arvat, E. Ghigo, F. Broglio, 2004, The Journal of clinical endocrinology and metabolism.

Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans

F. Casanueva, E. Arvat, E. Ghigo, 2003, Clinical endocrinology.

Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a.

H. Pols, H. Jahr, H. Chiba, 2006, The Journal of endocrinology.

Somatostatin, cortistatin, ghrelin and glucose metabolism.

C. Gauna, A. J. van der Lely, A. J. Van der Lely, 2005, Journal of endocrinological investigation.

What Every Internist-Endocrinologist Should Know about Rare Genetic Syndromes in Order to Prevent Needless Diagnostics, Missed Diagnoses and Medical Complications: Five Years of ‘Internal Medicine for Rare Genetic Syndromes’

A. J. van der Lely, A. Rosenberg, K. Pellikaan, 2021, Journal of clinical medicine.

Approach to the Patient With Treatment-resistant Acromegaly

A. J. van der Lely, S. Neggers, E. Coopmans, 2022, The Journal of clinical endocrinology and metabolism.

Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant

A. J. van der Lely, L. Hofland, A. Nagtegaal, 2016, Neuroendocrinology.